Literature DB >> 33350342

Expression of cytochrome P450 isozyme transcripts and activities in human livers.

Jie Liu1,2, Yuan-Fu Lu3, J Christopher Corton2, Curtis D Klaassen1.   

Abstract

Individual differences in cytochrome P450 (CYP) enzymes contribute to responses to drugs and environmental chemicals. The expression of CYPs is influenced by sex, age, and ethnicity. Human CYP studies are often conducted with human liver microsomes and liver cells to evaluate chemical induction and drug interactions. However, the basal or constitutive expression of CYP transcripts and enzyme activities in the intact liver are also important in our understanding of individual variation in CYPs. This study utilised 100 human liver samples to profile the constitutive expression of CYP1A2, 2B6, 2C8, 2C9, 2C19, 2D6, 2E1, 3A4, and 4A11 enzyme activity and transcript levels. The mRNA expression of the CYPs and xenobiotic receptors AhR, CAR, and PXR was examined via qPCR. Results showed that there was greater inter-individual variation in mRNA expression than in enzyme activities, except for CYP2C19. Females had higher CYP3A4 activity than males. Children had lower CYP4A14 activity, while elderly had lower P450 oxidoreductase activity. Compared to Caucasians, Hispanics had higher CYP2C8 activity and higher CYP2B6, CYP2C9, and CYP2C19 mRNA expression, whereas African Americans had lower CYP2D6 mRNA expression. These results add to our understanding of individual variations in xenobiotic metabolism and toxicology.

Entities:  

Keywords:  CYP mRNA expression; ; Cytochrome P450 activity; ; age; ; ethnicity; ; individual variation; ; sex;

Mesh:

Substances:

Year:  2020        PMID: 33350342      PMCID: PMC8215780          DOI: 10.1080/00498254.2020.1867929

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  36 in total

1.  Isolation and culture of primary hepatocytes from resected human liver tissue.

Authors:  Edward L Lecluyse; Eliane Alexandre
Journal:  Methods Mol Biol       Date:  2010

2.  ADME transcriptome in Hispanic versus White donor livers: evidence of a globally enhanced NR1I3 (CAR, constitutive androstane receptor) gene signature in Hispanics.

Authors:  D Finkelstein; V Lamba; M Assem; J Rengelshausen; K Yasuda; S Strom; E Schuetz
Journal:  Xenobiotica       Date:  2006 Oct-Nov       Impact factor: 1.908

3.  Developmental changes in human liver CYP2D6 expression.

Authors:  Jeffrey C Stevens; Sandra A Marsh; Matthew J Zaya; Karen J Regina; Karthika Divakaran; Min Le; Ronald N Hines
Journal:  Drug Metab Dispos       Date:  2008-05-12       Impact factor: 3.922

4.  Cytochrome P450 2B6 activity as measured by bupropion hydroxylation: effect of induction by rifampin and ethnicity.

Authors:  Katarzyna K Loboz; Annette S Gross; Kenneth M Williams; Winston S Liauw; Richard O Day; Julia K Blievernicht; Ulrich M Zanger; Andrew J McLachlan
Journal:  Clin Pharmacol Ther       Date:  2006-07       Impact factor: 6.875

5.  Genetic variation in metabolizing enzyme and transporter genes: comprehensive assessment in 3 major East Asian subpopulations with comparison to Caucasians and Africans.

Authors:  Michael Man; Mark Farmen; Carmen Dumaual; Choo Hua Teng; Brian Moser; Shin Irie; Gyu Jeong Noh; Reuben Njau; Sandra Close; Stephen Wise; Richard Hockett
Journal:  J Clin Pharmacol       Date:  2010-02-19       Impact factor: 3.126

Review 6.  The 2006 Bernard B. Brodie Award Lecture. Cyp2e1.

Authors:  Frank J Gonzalez
Journal:  Drug Metab Dispos       Date:  2006-10-04       Impact factor: 3.922

7.  Poor metabolizers at the cytochrome P450 2D6 and 2C19 loci are at increased risk of developing adult acute leukaemia.

Authors:  P L Roddam; S Rollinson; E Kane; E Roman; A Moorman; R Cartwright; G J Morgan
Journal:  Pharmacogenetics       Date:  2000-10

8.  The effect of age, sex, and rifampin administration on intestinal and hepatic cytochrome P450 3A activity.

Authors:  J Christopher Gorski; Suda Vannaprasaht; Mitchell A Hamman; Walter T Ambrosius; Melissa A Bruce; Barbara Haehner-Daniels; Stephen D Hall
Journal:  Clin Pharmacol Ther       Date:  2003-09       Impact factor: 6.875

9.  Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population.

Authors:  Joseph F Solus; Brenda J Arietta; James R Harris; David P Sexton; John Q Steward; Chara McMunn; Patrick Ihrie; Janelle M Mehall; Todd L Edwards; Elliott P Dawson
Journal:  Pharmacogenomics       Date:  2004-10       Impact factor: 2.533

Review 10.  The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes.

Authors:  Andrew Parkinson; Daniel R Mudra; Cory Johnson; Anne Dwyer; Kathleen M Carroll
Journal:  Toxicol Appl Pharmacol       Date:  2004-09-15       Impact factor: 4.219

View more
  7 in total

1.  The reference liver-CYP450 and UGT enzymes in healthy donor and metastatic livers: the impact of genotype.

Authors:  Mateusz Kurzawski; Sylwia Szeląg-Pieniek; Joanna Łapczuk-Romańska; Maciej Wrzesiński; Stefan Oswald; Marek Droździk
Journal:  Pharmacol Rep       Date:  2021-11-06       Impact factor: 3.024

2.  Associations of CYP2B6 genetic polymorphisms with Hirschsprung's disease in a southern Chinese population.

Authors:  Yanqing Liu; Chaoting Lan; Bingxiao Li; Ning Wang; Xiaoyu Zuo; Lihua Huang; Yuxin Wu; Yun Zhu
Journal:  J Clin Lab Anal       Date:  2021-11-09       Impact factor: 2.352

Review 3.  Cytochrome P450 Enzymes and Drug Metabolism in Humans.

Authors:  Mingzhe Zhao; Jingsong Ma; Mo Li; Yingtian Zhang; Bixuan Jiang; Xianglong Zhao; Cong Huai; Lu Shen; Na Zhang; Lin He; Shengying Qin
Journal:  Int J Mol Sci       Date:  2021-11-26       Impact factor: 5.923

4.  Induction by Phenobarbital of Phase I and II Xenobiotic-Metabolizing Enzymes in Bovine Liver: An Overall Catalytic and Immunochemical Characterization.

Authors:  Michela Cantiello; Monica Carletti; Mery Giantin; Giulia Gardini; Francesca Capolongo; Paolo Cascio; Marianna Pauletto; Flavia Girolami; Mauro Dacasto; Carlo Nebbia
Journal:  Int J Mol Sci       Date:  2022-03-24       Impact factor: 5.923

5.  Population pharmacokinetic modeling of benznidazole in Brazilian patients with chronic Chagas disease.

Authors:  Virgínia Paula Frade; Carlos Henrique Valente Moreira; Ester Cerdeira Sabino; Danilo César Galindo Bedor; Fábio de Rose Ghilard; Cláudia Di Lorenzo Oliveira; Cristina Sanches
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2022-02-02       Impact factor: 1.846

6.  Metabo-tip: a metabolomics platform for lifestyle monitoring supporting the development of novel strategies in predictive, preventive and personalised medicine.

Authors:  Julia Brunmair; Andrea Bileck; Thomas Stimpfl; Florian Raible; Giorgia Del Favero; Samuel M Meier-Menches; Christopher Gerner
Journal:  EPMA J       Date:  2021-05-04       Impact factor: 6.543

7.  CYP1A2 mRNA Expression Rather than Genetic Variants Indicate Hepatic CYP1A2 Activity.

Authors:  Ferenc Fekete; Katalin Mangó; Annamária Minus; Katalin Tóth; Katalin Monostory
Journal:  Pharmaceutics       Date:  2022-02-27       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.